Abstract:Human metapneumovirus (HMPV) is an important cause of acute lower respiratory infection in children and adults worldwide. There are four genetic subgroups of HMPV and both neutralizing antibodies and T cells contribute to protection. However, little is known about mechanisms of pathogenesis and most published work is based on a few extensively passaged, laboratory-adapted strains of HMPV. In this study, we isolated and characterized a panel of low passage HMPV clinical isolates representing all four genetic subgroups. The clinical isolates exhibited lower levels of in vitro replication compared to a lab-adapted strain. We compared disease phenotypes using a well-established mouse model. Several virulent isolates caused severe weight loss, lung pathology, airway dysfunction, and fatal disease in mice, which was confirmed in three inbred mouse strains. Disease severity did not correlate with lung viral titer, as virulent strains exhibited restricted replication in the lower airway. Virulent HMPV isolates were associated with markedly increased proinflammatory cytokine production and neutrophil influx; however, depletion of neutrophils or genetic ablation of inflammasome components did not reverse disease. Virulent clinical isolates induced markedly increased type I and type III IFN (IFN) secretion in vitro and in vivo . STAT1/2-deficient mice lacking both type I and type III IFN signaling showed reduced disease severity and increased lung viral replication. Inhibition of type I IFN signaling using a blocking antibody or genetic ablation of the type I IFN receptor reduced pathology with minimal effect on viral replication. Conversely, blockade of type III IFN signaling with a neutralizing antibody or genetic ablation of the IFN-lambda receptor had no effect on pathogenesis but restored viral replication. Collectively, these results demonstrate distinct roles for type I and type III IFN in HMPV pathogenesis and immunity. Human metapneumovirus (HMPV) is a leading cause of acute lower respiratory infection in children and adults worldwide. However, little is known about mechanisms of pathogenesis and most published studies use a few laboratory-adapted strains of HMPV. In this study, we isolated and characterized disease phenotypes of a panel of HMPV isolates. We identified several virulent isolates capable of causing severe and fatal disease in mice. Virulent HMPV isolates were associated with markedly increased proinflammatory cytokine production as well as increased type I and type III IFN (IFN) secretion in vitro and in vivo . Inhibition of type I IFN signaling reduced pathology with minimal effect on viral replication. Conversely, blockade or genetic ablation of type III IFN signaling had no effect on pathogenesis but restored viral replication. Collectively, these results demonstrate distinct roles for type I and type III IFN in HMPV defense and disease.

Actin cytoskeleton dynamics affect replication of Human Metapneumovirus

Epidemiology and Genetic Characterization of Human Metapneumovirus in Pediatric Patients from Hangzhou China

Prevalence of Human Metapneumovirus in Adults with Acute Respiratory Tract Infection in Beijing, China

Host Components That Modulate the Disease Caused by hMPV

Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System

Characterization of the interaction domains between the phosphoprotein and the nucleoprotein of human Metapneumovirus

Inhibition of Human Metapneumovirus Replication by Small Interfering RNA.

Interleukin-1β promotes human metapneumovirus replication via activating the cGAS-STING pathway

The Human Metapneumovirus Small Hydrophobic Protein Has Properties Consistent with Those of a Viroporin and Can Modulate Viral Fusogenic Activity

Clinical human metapneumovirus isolates show distinct pathogenesis and inflammatory profiles but similar CD8 + T cell impairment

Human metapneumovirus infection of organoid-derived human bronchial epithelium represents cell tropism and cytopathology as observed in in vivo models

Detection of human metapneumovirus in respiratory specimen by fluorescent quantitative PCR

Human metapneumovirus respiratory infection affects both innate and adaptive intestinal immunity

Human metapneumovirus P protein independently drives phase separation and recruits N protein to liquid-like inclusion bodies

Distinct roles for type I and type III interferons in virulent human metapneumovirus pathogenesis

Antiviral strategies against human metapneumovirus: Targeting the fusion protein

Exploring Chemical Space to Identify Partial Binders Against hMPV Nucleocapsid Protein

Advances in laboratory assays for detecting human metapneumovirus

Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats Sigmodon hispidus

Characterization of the Interaction between Human Respiratory Syncytial Virus and the Cell Cycle in Continuous Cell Culture and Primary Human Airway Epithelial Cells